Hangzhou Huqingyutang Pharmaceutical Co., Ltd.
Hangzhou Huqing Yutang Pharmaceutical Co., Ltd. was founded in 1874 (the 13th year of Tongzhi in the Qing Dynasty) by Hu Xueyan, a red-topped businessman in the Qing Dynasty, in Dajing Lane at the foot of Wushan. Its purpose is to help the people of Shining. Based on the prescriptions, traditional prescriptions, famous doctors' proven prescriptions and secret recipes of the official "Taiping Huimin Heji Pharmaceutical Bureau" in the Southern Song Dynasty, Hu Qingyutang produces pills, powders, pastes, dan, qu, lucidum, oil, wine, tablets, capsules, and granules. Hundreds of products such as dosage forms are one of the traditional Chinese medicine enterprises with a long history in my country and enjoy the reputation of "Jiangnan Medicine King". In the late 1990s, Hangzhou Huqing Yutang Pharmaceutical Co., Ltd. was located on the banks of the beautiful Qiantang River. It inherited Huqing Yutang's 100-year "refrain from bullying" spirit, completed the process of moving from traditional workshops to modernization, and became a high-tech technology. enterprise. In 2011, the company obtained the ISO14001 environmental management system certification certificate. In 2017, it passed the "National Second-level" safety production standardization evaluation. In 2018, the company obtained the ISO9001 quality system certification certificate. The medicines and health foods produced by the company have passed the national drug GMP certification and the Zhejiang Province health food GMP certification. In early 2012, in order to meet the requirements of Hangzhou's urban construction and the company's own development needs, the company built a garden-style traditional Chinese medicine production base covering an area of 107 mu and a construction area of 70,398.86 square meters in Yuhang Economic and Technological Development Zone. At the end of 2015, the company moved from No. 78-10 Hanghai Road, Jianggan District, Hangzhou to No. 70 Xinzhou Road, Yuhang Economic and Technological Development Zone, opening a new cultural heritage and business development of Hu Qingyutang Pharmaceutical in Yuhang Economic and Technological Development Zone. Chapter. The company now has 184 drugs and 9 health foods approved by the state. It has 6 invention patents, 7 new utility patents, and 13 appearance patents. Mainly produces Silicone Ning tablets (national Class III new medicine), Weifuchun tablets, Xiaolexia Teng Granules, Zhayi San, Qingyu Jiuxin Pills (Shenxiang Suhe Pills), Qiju Dihuang Oral Liquid, Chenxiang Huaqi Capsules, Wei Fuchun tablets, compound Salvia miltiorrhiza tablets, Angong Niuhuang Pills, Iron Maple Dou Jing, Propolis Capsules, American Ginseng Oral Liquid, etc. In recent years, the company has combined the advantages and characteristics of century-old traditional Chinese medicine with modern science and technology to create a traditional Chinese medicine research institution - Zhejiang Traditional Chinese Medicine Modernization Research and Development Center. It inherited and explored the "Hu Qingyutang Integrated Prescription" and used the famous old Chinese medicine prescriptions. , secret recipes, learn from the development experience of modern medicine and international natural medicines, constantly innovate, develop new Chinese medicine products with independent intellectual property rights, develop various Chinese patent medicines and health foods, and form products that produce traditional Chinese patent medicines and health foods. structure. In the long river of history, Hu Qingyutang Pharmaceutical adheres to Hu Xueyan's spirit of honest pharmaceuticals such as "quitting bullying", "recruiting and doing business", and is deeply rooted in the brand, quality and reputation of its brand, quality and reputation Among the people. Looking forward to the future, Hu Qingyutang Pharmaceutical will operate in a new production base and achieve sustainable development with evergreen foundations. It will continue to adhere to the path of combining the characteristics of traditional Chinese medicine with modern technology for a century, explore the treasure house of traditional Chinese medicine, and actively develop independent intellectual property rights. new Chinese medicine. Carry forward the spirit of a century-old store, enhance the century-old brand, accelerate development, make greater contributions to the revitalization of national medicine and benefiting the health of the people, and also add luster to the golden signboard of Hu Qingyutang.
Hangzhou Huqingyutang Pharmaceutical Co., Ltd.
Hangzhou Huqing Yutang Pharmaceutical Co., Ltd. was founded in 1874 (the 13th year of Tongzhi in the Qing Dynasty) by Hu Xueyan, a red-topped businessman in the Qing Dynasty, in Dajing Lane at the foot of Wushan. Its purpose is to help the people of Shining. Based on the prescriptions, traditional prescriptions, famous doctors' proven prescriptions and secret recipes of the official "Taiping Huimin Heji Pharmaceutical Bureau" in the Southern Song Dynasty, Hu Qingyutang produces pills, powders, pastes, dan, qu, lucidum, oil, wine, tablets, capsules, and granules. Hundreds of products such as dosage forms are one of the traditional Chinese medicine enterprises with a long history in my country and enjoy the reputation of "Jiangnan Medicine King". In the late 1990s, Hangzhou Huqing Yutang Pharmaceutical Co., Ltd. was located on the banks of the beautiful Qiantang River. It inherited Huqing Yutang's 100-year "refrain from bullying" spirit, completed the process of moving from traditional workshops to modernization, and became a high-tech technology. enterprise. In 2011, the company obtained the ISO14001 environmental management system certification certificate. In 2017, it passed the "National Second-level" safety production standardization evaluation. In 2018, the company obtained the ISO9001 quality system certification certificate. The medicines and health foods produced by the company have passed the national drug GMP certification and the Zhejiang Province health food GMP certification. In early 2012, in order to meet the requirements of Hangzhou's urban construction and the company's own development needs, the company built a garden-style traditional Chinese medicine production base covering an area of 107 mu and a construction area of 70,398.86 square meters in Yuhang Economic and Technological Development Zone. At the end of 2015, the company moved from No. 78-10 Hanghai Road, Jianggan District, Hangzhou to No. 70 Xinzhou Road, Yuhang Economic and Technological Development Zone, opening a new cultural heritage and business development of Hu Qingyutang Pharmaceutical in Yuhang Economic and Technological Development Zone. Chapter. The company now has 184 drugs and 9 health foods approved by the state. It has 6 invention patents, 7 new utility patents, and 13 appearance patents. Mainly produces Silicone Ning tablets (national Class III new medicine), Weifuchun tablets, Xiaolexia Teng Granules, Zhayi San, Qingyu Jiuxin Pills (Shenxiang Suhe Pills), Qiju Dihuang Oral Liquid, Chenxiang Huaqi Capsules, Wei Fuchun tablets, compound Salvia miltiorrhiza tablets, Angong Niuhuang Pills, Iron Maple Dou Jing, Propolis Capsules, American Ginseng Oral Liquid, etc. In recent years, the company has combined the advantages and characteristics of century-old traditional Chinese medicine with modern science and technology to create a traditional Chinese medicine research institution - Zhejiang Traditional Chinese Medicine Modernization Research and Development Center. It inherited and explored the "Hu Qingyutang Integrated Prescription" and used the famous old Chinese medicine prescriptions. , secret recipes, learn from the development experience of modern medicine and international natural medicines, constantly innovate, develop new Chinese medicine products with independent intellectual property rights, develop various Chinese patent medicines and health foods, and form products that produce traditional Chinese patent medicines and health foods. structure. In the long river of history, Hu Qingyutang Pharmaceutical adheres to Hu Xueyan's spirit of honest pharmaceuticals such as "quitting bullying", "recruiting and doing business", and is deeply rooted in the brand, quality and reputation of its brand, quality and reputation Among the people. Looking forward to the future, Hu Qingyutang Pharmaceutical will operate in a new production base and achieve sustainable development with evergreen foundations. It will continue to adhere to the path of combining the characteristics of traditional Chinese medicine with modern technology for a century, explore the treasure house of traditional Chinese medicine, and actively develop independent intellectual property rights. new Chinese medicine. Carry forward the spirit of a century-old store, enhance the century-old brand, accelerate development, make greater contributions to the revitalization of national medicine and benefiting the health of the people, and also add luster to the golden signboard of Hu Qingyutang.
Jiangxi Baishen Pharmaceutical Co., Ltd.
Jiangxi Baishen Pharmaceutical Co., Ltd. was founded in 2002 and is located in Yuanzhou Pharmaceutical Industrial Park, Yichun City. It is a modern pharmaceutical enterprise integrating the research and development, production and sales of patent medicines, traditional Chinese medicine formula granules, and Chinese herbal medicines. It has Jiangxi Baishen Changnuo Pharmaceutical Co., Ltd. and Jiangxi Baishen Pharmaceutical Co., Ltd. are two wholly-owned subsidiaries. The company has 1 national engineering research center, 1 academician workstation, 2 provincial enterprise technology centers, and 1 provincial laboratory. It has carried out drug research and development cooperation with well-known domestic drug research and development institutions and more than 10 listed pharmaceutical companies, and has strong R&D strength and technical level. During the 12th Five-Year Plan period, the company twice undertakes major scientific research tasks for the national "major new drug creation" science and technology, and has been successfully completed. The company has two major production bases in Yichun and Fuzhou, covering an area of 517 mu, with a factory area of more than 80,000 square meters, and has numerous production equipment and more than 10 modern production lines. The company adheres to the concept of quality first and strictly follows the requirements of GMP and GSP to produce and operate high-quality medicines. The company has more than 10 pharmaceutical dosage forms and health foods, with more than 600 production approval documents, covering more than 8 major series and more than 600 varieties, forming a complete group of traditional Chinese medicine series products. Baishen brand products are deeply loved by customers and consumers for their advantages in quality, efficacy, brand and other advantages. The company has a professional marketing team that adheres to customer-centricity and implements three major driving forces for customers, including policies, emotions and goals, forming a nationwide marketing network, with sales revenue growing year by year.
Jiangxi Baishen Pharmaceutical Co., Ltd.
Jiangxi Baishen Pharmaceutical Co., Ltd. was founded in 2002 and is located in Yuanzhou Pharmaceutical Industrial Park, Yichun City. It is a modern pharmaceutical enterprise integrating the research and development, production and sales of patent medicines, traditional Chinese medicine formula granules, and Chinese herbal medicines. It has Jiangxi Baishen Changnuo Pharmaceutical Co., Ltd. and Jiangxi Baishen Pharmaceutical Co., Ltd. are two wholly-owned subsidiaries. The company has 1 national engineering research center, 1 academician workstation, 2 provincial enterprise technology centers, and 1 provincial laboratory. It has carried out drug research and development cooperation with well-known domestic drug research and development institutions and more than 10 listed pharmaceutical companies, and has strong R&D strength and technical level. During the 12th Five-Year Plan period, the company twice undertakes major scientific research tasks for the national "major new drug creation" science and technology, and has been successfully completed. The company has two major production bases in Yichun and Fuzhou, covering an area of 517 mu, with a factory area of more than 80,000 square meters, and has numerous production equipment and more than 10 modern production lines. The company adheres to the concept of quality first and strictly follows the requirements of GMP and GSP to produce and operate high-quality medicines. The company has more than 10 pharmaceutical dosage forms and health foods, with more than 600 production approval documents, covering more than 8 major series and more than 600 varieties, forming a complete group of traditional Chinese medicine series products. Baishen brand products are deeply loved by customers and consumers for their advantages in quality, efficacy, brand and other advantages. The company has a professional marketing team that adheres to customer-centricity and implements three major driving forces for customers, including policies, emotions and goals, forming a nationwide marketing network, with sales revenue growing year by year.
China Resources Pharmaceutical Holdings Co., Ltd.
China Resources Sanjiu Pharmaceutical Co., Ltd. (hereinafter referred to as "China Resources Sanjiu") is a large state-owned pharmaceutical listed company, mainly engaged in the research and development, production, sales and related health services of pharmaceutical products. Up to now, China Resources Sanjiu has been included in the Shenzhen Component Index, CSI 500 and FTSE Russell Index. China Resources Sanjiu was predecessored by Shenzhen Southern Pharmaceutical Factory established in 1985. In 1999, five companies including Sanjiu Enterprise Group and Shenzhen Sanjiu Pharmaceutical Co., Ltd. initiated the establishment of joint-stock companies; on March 9, 2000, it was listed on the Shenzhen Stock Exchange (stock code is 000999); in 2008, Officially entered China Resources Group; in 2010, the company's name was changed from "Sanjiu Pharmaceutical Co., Ltd." to "China Resources Sanjiu Pharmaceutical Co., Ltd.". China Resources Sanjiu’s main core business is positioned in the fields of CHC health consumer goods and prescription drugs, with a rich product line and a continuous enrichment of varieties. CHC's health consumer products business covers nearly 10 categories including colds, skin, gastrointestinal tract, cough relieving, orthopedics, pediatrics, dietary nutritional supplements, and its core products occupy a high market share; prescription drug business covers cardiovascular, anti-tumor, Digestive system, orthopedics, pediatrics, anti-infection and other treatment fields, it has the Xuesaitong Panax notoginseng series products, Shenfu injection, mitoxantrone hydrochloride injection for tracer, Huachansu tablets and injections, Yixuesheng Capsule , blood stasis, and sodium cefbiroster for injection have a high reputation in the medical end. In 2023, China Resources Sanjiu has 39 varieties with annual sales of over 100 million yuan, including "999 Cold Ling", "999 Dermatitis Ping", "Sanjiu Weitai", "999 Children's Cold Granules", and "999 Antiviral Oral Liquid ", "Qizhiwei Puer Granules", "Tianhe Gutong Tie Paste", "Yi Shanfu", "999 Aonuo Calcium Gluconate Zinc Oral Solution", "Xuesaitong Panax noto Series Products", "Kun Chinese Medicine Ginseng Lingjianpiwei Granules", "Afacalciferol Soft Capsules", "Sodium Hyaluronic Acid Injection" and so on have a leading position in related categories. The "999" brand enjoys high recognition in both the consumer and pharmaceutical industries. China Resources Sanjiu has always attached great importance to R&D and innovation. During the "14th Five-Year Plan" strategic period, China Resources Sanjiu will focus on the strategic direction, continue to increase R&D investment, improve the construction of innovation systems and mechanisms, and enhance innovation and development capabilities. While increasing the cooperation between industry, academia and research, three research institutes of innovative drugs, traditional Chinese medicine and health drugs have been established and operated one after another; innovative cooperation with Shenzhen Bay Laboratory has been carried out in depth, and clinical related to the QBH-196 project of anti-tumor innovative drug QBH-196 project has been vigorously promoted. Research. In 2023, R&D investment was 889 million yuan, and the proportion of new product R&D investment increased. There are a total of 112 projects under development, mainly focusing on anti-tumor, orthopedics, skin, respiratory, anti-infection and other treatment fields, and in new product project establishment, product R&D, and product strength. Positive progress has been made in areas such as improvement. China Resources Sanjiu attaches great importance to the inheritance and innovation of traditional Chinese medicine, continues to deepen the full-process development system of traditional Chinese medicine, precipitates the research and development capabilities of traditional Chinese medicine, and focuses on the research on classic prescriptions of traditional Chinese medicine, standards of traditional Chinese medicine formula granules and medicinal materials resources. The classic prescription embodies the essence of traditional Chinese medicine. The company adheres to the research idea of "inheriting the essence, keeping the truth and innovation", focuses on the elderly, women, and children, covering the treatment fields of breathing, heart and brain, digestion, etc., and carries out "Medicinal Materials-Decoction-Benchmark Sample- Systematic research on compound preparations, and build a traceability system for the entire industrial chain of traditional Chinese medicine. China Resources Sanjiu continues to pay attention to high-quality domestic and foreign resources, and makes strategic mergers and acquisitions integration efforts. Among them, China Resources Sanjiu and its holding subsidiary Kunzi Pharmaceutical Group have good synergy in terms of brands, products, channels, etc., and the business integration is progressing smoothly. We empower each other in the development of the Panax notoginseng industry and the creation of the "Kunzi Chinese Medicine 1381" brand. Coordinated development will promote Kunming Pharmaceutical Group to become the first healthy stock in silver economics. Against the backdrop of the ever-changing environment of the pharmaceutical industry, China Resources Sanjiu embraces industry and market development opportunities, leads "high-quality development" with innovation, adheres to the dual-wheel drive of "brand + innovation", and focuses on innovation and research and development of high-quality pharmaceutical and health products and intelligent manufacturing , optimize business layout, strengthen brand and channel construction, increase innovation investment, actively explore innovative development models of industrial chains, build competitive advantages of the entire industrial chain of traditional Chinese medicine, improve operational quality and efficiency, and achieve steady improvement in operating performance and core capabilities. During the "14th Five-Year Plan" strategic period, China Resources Sanjiu made solid progress on the road to becoming a leading enterprise in the industry, benchmarking against world-class enterprises, improving business layout, expanding its core business into the entire field of self-diagnosis and treatment, developing business focus on pipelines, and as the core Business empowerment to form a business model with "deep roots and lush leaves". Looking to the future, China Resources Sanjiu will always keep in mind its original mission and work hard to work hard. Under the mission of "caring for public health and creating a better life together", we will forge ahead to the goal of "leader of the mass medical and health industry" and serve Every member of the Chinese family.
China Resources Pharmaceutical Holdings Co., Ltd.
China Resources Sanjiu Pharmaceutical Co., Ltd. (hereinafter referred to as "China Resources Sanjiu") is a large state-owned pharmaceutical listed company, mainly engaged in the research and development, production, sales and related health services of pharmaceutical products. Up to now, China Resources Sanjiu has been included in the Shenzhen Component Index, CSI 500 and FTSE Russell Index. China Resources Sanjiu was predecessored by Shenzhen Southern Pharmaceutical Factory established in 1985. In 1999, five companies including Sanjiu Enterprise Group and Shenzhen Sanjiu Pharmaceutical Co., Ltd. initiated the establishment of joint-stock companies; on March 9, 2000, it was listed on the Shenzhen Stock Exchange (stock code is 000999); in 2008, Officially entered China Resources Group; in 2010, the company's name was changed from "Sanjiu Pharmaceutical Co., Ltd." to "China Resources Sanjiu Pharmaceutical Co., Ltd.". China Resources Sanjiu’s main core business is positioned in the fields of CHC health consumer goods and prescription drugs, with a rich product line and a continuous enrichment of varieties. CHC's health consumer products business covers nearly 10 categories including colds, skin, gastrointestinal tract, cough relieving, orthopedics, pediatrics, dietary nutritional supplements, and its core products occupy a high market share; prescription drug business covers cardiovascular, anti-tumor, Digestive system, orthopedics, pediatrics, anti-infection and other treatment fields, it has the Xuesaitong Panax notoginseng series products, Shenfu injection, mitoxantrone hydrochloride injection for tracer, Huachansu tablets and injections, Yixuesheng Capsule , blood stasis, and sodium cefbiroster for injection have a high reputation in the medical end. In 2023, China Resources Sanjiu has 39 varieties with annual sales of over 100 million yuan, including "999 Cold Ling", "999 Dermatitis Ping", "Sanjiu Weitai", "999 Children's Cold Granules", and "999 Antiviral Oral Liquid ", "Qizhiwei Puer Granules", "Tianhe Gutong Tie Paste", "Yi Shanfu", "999 Aonuo Calcium Gluconate Zinc Oral Solution", "Xuesaitong Panax noto Series Products", "Kun Chinese Medicine Ginseng Lingjianpiwei Granules", "Afacalciferol Soft Capsules", "Sodium Hyaluronic Acid Injection" and so on have a leading position in related categories. The "999" brand enjoys high recognition in both the consumer and pharmaceutical industries. China Resources Sanjiu has always attached great importance to R&D and innovation. During the "14th Five-Year Plan" strategic period, China Resources Sanjiu will focus on the strategic direction, continue to increase R&D investment, improve the construction of innovation systems and mechanisms, and enhance innovation and development capabilities. While increasing the cooperation between industry, academia and research, three research institutes of innovative drugs, traditional Chinese medicine and health drugs have been established and operated one after another; innovative cooperation with Shenzhen Bay Laboratory has been carried out in depth, and clinical related to the QBH-196 project of anti-tumor innovative drug QBH-196 project has been vigorously promoted. Research. In 2023, R&D investment was 889 million yuan, and the proportion of new product R&D investment increased. There are a total of 112 projects under development, mainly focusing on anti-tumor, orthopedics, skin, respiratory, anti-infection and other treatment fields, and in new product project establishment, product R&D, and product strength. Positive progress has been made in areas such as improvement. China Resources Sanjiu attaches great importance to the inheritance and innovation of traditional Chinese medicine, continues to deepen the full-process development system of traditional Chinese medicine, precipitates the research and development capabilities of traditional Chinese medicine, and focuses on the research on classic prescriptions of traditional Chinese medicine, standards of traditional Chinese medicine formula granules and medicinal materials resources. The classic prescription embodies the essence of traditional Chinese medicine. The company adheres to the research idea of "inheriting the essence, keeping the truth and innovation", focuses on the elderly, women, and children, covering the treatment fields of breathing, heart and brain, digestion, etc., and carries out "Medicinal Materials-Decoction-Benchmark Sample- Systematic research on compound preparations, and build a traceability system for the entire industrial chain of traditional Chinese medicine. China Resources Sanjiu continues to pay attention to high-quality domestic and foreign resources, and makes strategic mergers and acquisitions integration efforts. Among them, China Resources Sanjiu and its holding subsidiary Kunzi Pharmaceutical Group have good synergy in terms of brands, products, channels, etc., and the business integration is progressing smoothly. We empower each other in the development of the Panax notoginseng industry and the creation of the "Kunzi Chinese Medicine 1381" brand. Coordinated development will promote Kunming Pharmaceutical Group to become the first healthy stock in silver economics. Against the backdrop of the ever-changing environment of the pharmaceutical industry, China Resources Sanjiu embraces industry and market development opportunities, leads "high-quality development" with innovation, adheres to the dual-wheel drive of "brand + innovation", and focuses on innovation and research and development of high-quality pharmaceutical and health products and intelligent manufacturing , optimize business layout, strengthen brand and channel construction, increase innovation investment, actively explore innovative development models of industrial chains, build competitive advantages of the entire industrial chain of traditional Chinese medicine, improve operational quality and efficiency, and achieve steady improvement in operating performance and core capabilities. During the "14th Five-Year Plan" strategic period, China Resources Sanjiu made solid progress on the road to becoming a leading enterprise in the industry, benchmarking against world-class enterprises, improving business layout, expanding its core business into the entire field of self-diagnosis and treatment, developing business focus on pipelines, and as the core Business empowerment to form a business model with "deep roots and lush leaves". Looking to the future, China Resources Sanjiu will always keep in mind its original mission and work hard to work hard. Under the mission of "caring for public health and creating a better life together", we will forge ahead to the goal of "leader of the mass medical and health industry" and serve Every member of the Chinese family.
Hainan Calabash Kids Pharmaceutical Group Co., Ltd.
Huluwa Pharmaceutical Group takes "Healthy Chinese Babies" as its corporate mission to protect the healthy growth of Chinese children and is committed to building a national brand of Chinese children's medicine. Huluwa Pharmaceutical Group is a group enterprise with Haikou as its headquarters. It was reorganized in 2008 and was listed on the main board of the Shanghai Stock Exchange in July 2020 (stock abbreviation: Huluwa, stock code: 605199). After more than ten years of development, the group has worked hard in the field of pediatric medicine, focusing on building the entire life cycle of children and the full category of health and product industry chain, firmly following the development of pediatric medicine, and has now become one of the leading enterprises in the field of professional pediatric medicine. , and was selected as the vice chairman of the Pediatrics Branch of the Chinese Society of Traditional Chinese Medicine and the vice president of the Pediatrics Branch of the Chinese Society of Ethnic Medicine. The group focuses on scientific and technological innovation, lean production, brand building and professional services. It has now built two major production bases in Haikou, Hainan and Nanning, Guangxi. The Haikou Mei'an Children's Medicine Intelligent Manufacturing Base will be put into production this year; a total of 34 production and sales are Children's medicines, the main products include pediatric lung heat cough and asthma granules, enteroyanning series, compound lysine granules, etc., with about 120 products under development; the sales network covers more than 2,300 counties and cities in all provinces and regions. In addition, the group has successively established academician workstations, postdoctoral research workstations, Hainan Traditional Chinese Medicine Preparation Engineering Technology Research Center, and the Joint Development Laboratory of Southern Pharmaceuticals, and jointly built an international innovation platform for high-end children's preparations research and development with well-known domestic R&D companies. At the same time, after going public, the group has integrated various management work into ESG governance and actively assumed social responsibilities. Every year, through the children's committees of various industry societies and associations, it invested a lot of resources to ensure the safe use of medicine for children. We launched a public welfare project such as the "Spring Bree Class" that donated money to girls to enroll, and we have donated and expressed condolences to Haikou Social Welfare Institute for 7 consecutive years. Huluwa Pharmaceutical Group insists on party building to lead the high-quality development of the enterprise, relying on the historical opportunity of the construction of Hainan Free Trade Port, continues to deepen changes with the new development concept, constantly improve product quality and craftsmanship with the spirit of craftsmanship, and wins market recognition with professional services. We will strive to become the guardian of China's children's health field, help China move from a major pharmaceutical manufacturing country to a strong pharmaceutical innovation country, and contribute the strength of the Huluwa in the new journey of promoting the great rejuvenation of the Chinese nation with Chinese-style modernization!
Hainan Calabash Kids Pharmaceutical Group Co., Ltd.
Huluwa Pharmaceutical Group takes "Healthy Chinese Babies" as its corporate mission to protect the healthy growth of Chinese children and is committed to building a national brand of Chinese children's medicine. Huluwa Pharmaceutical Group is a group enterprise with Haikou as its headquarters. It was reorganized in 2008 and was listed on the main board of the Shanghai Stock Exchange in July 2020 (stock abbreviation: Huluwa, stock code: 605199). After more than ten years of development, the group has worked hard in the field of pediatric medicine, focusing on building the entire life cycle of children and the full category of health and product industry chain, firmly following the development of pediatric medicine, and has now become one of the leading enterprises in the field of professional pediatric medicine. , and was selected as the vice chairman of the Pediatrics Branch of the Chinese Society of Traditional Chinese Medicine and the vice president of the Pediatrics Branch of the Chinese Society of Ethnic Medicine. The group focuses on scientific and technological innovation, lean production, brand building and professional services. It has now built two major production bases in Haikou, Hainan and Nanning, Guangxi. The Haikou Mei'an Children's Medicine Intelligent Manufacturing Base will be put into production this year; a total of 34 production and sales are Children's medicines, the main products include pediatric lung heat cough and asthma granules, enteroyanning series, compound lysine granules, etc., with about 120 products under development; the sales network covers more than 2,300 counties and cities in all provinces and regions. In addition, the group has successively established academician workstations, postdoctoral research workstations, Hainan Traditional Chinese Medicine Preparation Engineering Technology Research Center, and the Joint Development Laboratory of Southern Pharmaceuticals, and jointly built an international innovation platform for high-end children's preparations research and development with well-known domestic R&D companies. At the same time, after going public, the group has integrated various management work into ESG governance and actively assumed social responsibilities. Every year, through the children's committees of various industry societies and associations, it invested a lot of resources to ensure the safe use of medicine for children. We launched a public welfare project such as the "Spring Bree Class" that donated money to girls to enroll, and we have donated and expressed condolences to Haikou Social Welfare Institute for 7 consecutive years. Huluwa Pharmaceutical Group insists on party building to lead the high-quality development of the enterprise, relying on the historical opportunity of the construction of Hainan Free Trade Port, continues to deepen changes with the new development concept, constantly improve product quality and craftsmanship with the spirit of craftsmanship, and wins market recognition with professional services. We will strive to become the guardian of China's children's health field, help China move from a major pharmaceutical manufacturing country to a strong pharmaceutical innovation country, and contribute the strength of the Huluwa in the new journey of promoting the great rejuvenation of the Chinese nation with Chinese-style modernization!
Jiangxi Chuanqi Pharmaceutical Co., Ltd.
Jiangxi Chuanqi Pharmaceutical Co., Ltd. is located in the National High-tech International Pharmaceutical Industrial Park in Nanchang City, Jiangxi Province, covering an area of 80,000 square meters. The factory has three national standard production workshops (pharmaceutical production workshop, health food production workshop, and organic selenium. Extraction workshop), with more than 30 modern production lines, a total of 24,000 square meters, and a national-level traditional Chinese medicine extraction workshop and an international standard warehouse of 12,000 square meters. Jiangxi Chuanqi Pharmaceutical Co., Ltd. is a high-tech enterprise in Jiangxi Province. The company has significant advantages such as strong technical R&D strength, advanced production equipment, and scientific management. In 2004, it passed the national drug and health products GMP certification, and can produce various products. , Western medicine, tablets, capsules, granules, oral liquids, syrups and powders, etc., all kinds of products have complete dosage forms. The main products are: Huang Jitong Capsules, Ganlang Capsules, Qiangli Loquat Decoction Granules, Liganlong Granules, Isatis root Granules, Wenweishu Tablets, Yangweishu Tablets, Metronidazole vaginal effervescent tablets, Fukang Tablets , Compound Xingxiang Rabbit Ear Wind Tablets, Vitamin C chewable tablets, Feishi Tablets, Hygienic Tablets, Bone-Burning High Calcium Tablets, Calcium Gluconate Oral Solution, Iron-Zinc Calcium Amino Acid Oral Solution, Hygienic Food Chew oral Solution, Hygienic Food Cheju Oral Solution, etc. Through thirteen years of independent research and development, the company successfully obtained the organic selenium known as the "21st amino acid in the human body" by chemical synthesis: (L-selenium methyl selenocysteine) (purity is 96%. ) Raw materials have been awarded 5 national invention patents, and have been approved as a new food nutritional enhancer by Announcement No. 11 of the National Health and Family Planning Commission, and have been included in the national standard of GB2760-14880. It also obtained the production license of the General Administration of Quality Supervision, Inspection and Quarantine. It is officially It was included in the national standard for organic selenium L-selenium methyl selenocysteine raw materials and was included in the list of health food raw materials of the State Food and Drug Administration in 2015. Related products include Oselivikang, Sedoduo, etc., which are new food nutritional enhancers with broad market prospects. After more than 30 years of ups and downs in the health care product market, Chuanqi has developed into a well-known enterprise in the health food industry in Jiangxi Province. It has nearly 20 provincial offices and more than 2,000 market sales outlets in China. The company has developed and produced: enhancing immunity, replenishing blood, replenishing iron, replenishing zinc, replenishing calcium, replenishing vitamins, replenishing kidneys, clearing throat, moistening intestines and laxatives, lowering lipids, lowering sugar, strengthening stomach and digesting food, and improving sleep More than 40 health foods for "national food and health" including beauty, weight loss, freckle removal, anti-aging, and lead removal. Relying on advanced technology and excellent product quality, Chuanqi Health Products has accumulated a good reputation in the market. Many products are included in the list of key protected products in Jiangxi Province, and some products have been exported to the United States, Australia and other countries. Jiangxi Chuanqi Pharmaceutical Co., Ltd. has always been pioneering and innovative, and constantly making progress with the business philosophy of "being good people, making good medicines, and serving the people". The company insists on the same as before, benefiting the people, serving the national health industry, and serving the health of mankind. Continuous efforts in career.
Jiangxi Chuanqi Pharmaceutical Co., Ltd.
Jiangxi Chuanqi Pharmaceutical Co., Ltd. is located in the National High-tech International Pharmaceutical Industrial Park in Nanchang City, Jiangxi Province, covering an area of 80,000 square meters. The factory has three national standard production workshops (pharmaceutical production workshop, health food production workshop, and organic selenium. Extraction workshop), with more than 30 modern production lines, a total of 24,000 square meters, and a national-level traditional Chinese medicine extraction workshop and an international standard warehouse of 12,000 square meters. Jiangxi Chuanqi Pharmaceutical Co., Ltd. is a high-tech enterprise in Jiangxi Province. The company has significant advantages such as strong technical R&D strength, advanced production equipment, and scientific management. In 2004, it passed the national drug and health products GMP certification, and can produce various products. , Western medicine, tablets, capsules, granules, oral liquids, syrups and powders, etc., all kinds of products have complete dosage forms. The main products are: Huang Jitong Capsules, Ganlang Capsules, Qiangli Loquat Decoction Granules, Liganlong Granules, Isatis root Granules, Wenweishu Tablets, Yangweishu Tablets, Metronidazole vaginal effervescent tablets, Fukang Tablets , Compound Xingxiang Rabbit Ear Wind Tablets, Vitamin C chewable tablets, Feishi Tablets, Hygienic Tablets, Bone-Burning High Calcium Tablets, Calcium Gluconate Oral Solution, Iron-Zinc Calcium Amino Acid Oral Solution, Hygienic Food Chew oral Solution, Hygienic Food Cheju Oral Solution, etc. Through thirteen years of independent research and development, the company successfully obtained the organic selenium known as the "21st amino acid in the human body" by chemical synthesis: (L-selenium methyl selenocysteine) (purity is 96%. ) Raw materials have been awarded 5 national invention patents, and have been approved as a new food nutritional enhancer by Announcement No. 11 of the National Health and Family Planning Commission, and have been included in the national standard of GB2760-14880. It also obtained the production license of the General Administration of Quality Supervision, Inspection and Quarantine. It is officially It was included in the national standard for organic selenium L-selenium methyl selenocysteine raw materials and was included in the list of health food raw materials of the State Food and Drug Administration in 2015. Related products include Oselivikang, Sedoduo, etc., which are new food nutritional enhancers with broad market prospects. After more than 30 years of ups and downs in the health care product market, Chuanqi has developed into a well-known enterprise in the health food industry in Jiangxi Province. It has nearly 20 provincial offices and more than 2,000 market sales outlets in China. The company has developed and produced: enhancing immunity, replenishing blood, replenishing iron, replenishing zinc, replenishing calcium, replenishing vitamins, replenishing kidneys, clearing throat, moistening intestines and laxatives, lowering lipids, lowering sugar, strengthening stomach and digesting food, and improving sleep More than 40 health foods for "national food and health" including beauty, weight loss, freckle removal, anti-aging, and lead removal. Relying on advanced technology and excellent product quality, Chuanqi Health Products has accumulated a good reputation in the market. Many products are included in the list of key protected products in Jiangxi Province, and some products have been exported to the United States, Australia and other countries. Jiangxi Chuanqi Pharmaceutical Co., Ltd. has always been pioneering and innovative, and constantly making progress with the business philosophy of "being good people, making good medicines, and serving the people". The company insists on the same as before, benefiting the people, serving the national health industry, and serving the health of mankind. Continuous efforts in career.
King To Nin Jiom Medicine Manufactory Co., Ltd.
Since its establishment in 1946, Kyoto Nianci An has been producing the century-old Milian Chuanbei loquat paste, and has been expanding continuously during this period. It has now become one of the manufacturers leading the development of Chinese patent medicines in Hong Kong. The natural Chinese herbal medicine products produced are sold well. Globally renowned. In order to cooperate with the demand for natural Chinese herbal products outside Hong Kong and even around the world, Kyoto Nianci'an will develop a series of convenient and effective herbal products to fundamentally help customers by combining advanced technology and strict quality control, combining extensive traditional Chinese herbal knowledge. Solve various physical discomfort symptoms, whether it is colds, throat pain, cough and sticky phlegm, heat and heat, menstrual pain and discomfort, or even acne.
King To Nin Jiom Medicine Manufactory Co., Ltd.
Since its establishment in 1946, Kyoto Nianci An has been producing the century-old Milian Chuanbei loquat paste, and has been expanding continuously during this period. It has now become one of the manufacturers leading the development of Chinese patent medicines in Hong Kong. The natural Chinese herbal medicine products produced are sold well. Globally renowned. In order to cooperate with the demand for natural Chinese herbal products outside Hong Kong and even around the world, Kyoto Nianci'an will develop a series of convenient and effective herbal products to fundamentally help customers by combining advanced technology and strict quality control, combining extensive traditional Chinese herbal knowledge. Solve various physical discomfort symptoms, whether it is colds, throat pain, cough and sticky phlegm, heat and heat, menstrual pain and discomfort, or even acne.
Jiangxi Tengwangge Pharmaceutical Co., Ltd.
Jiangxi Tengwangge Pharmaceutical Co., Ltd. (hereinafter referred to as "Tengwangge Pharmaceutical") was established in 1989. After its transformation, it has become a Sino-foreign joint venture and mainly produces Chinese patent medicines. It is now located in the beautiful scenery of Changbei Economic Development Zone, Nanchang City. Meilingjiao covers an area of 68 mu, with a factory building and its auxiliary building area of 16,800 square meters. The company currently has 160 employees, 73 people with college degree or above, accounting for 45.6%, of which 39 people with scientific and technological personnel, accounting for 24.3%. The scientific and technological research and development team covers multiple majors such as pharmacy, traditional Chinese medicine, pharmaceutical engineering, bioengineering, and mechanical manufacturing. The company has the domestic advanced Chinese medicine extraction and concentration production line, granule preparation production line, oral liquid production line, as well as two decoction and syrup production lines integrating automatic bottle washing, filling, capping, cleaning, drying and labeling of bottles; It has a total of 52 varieties and more than 100 specifications of various products with "Tengwang Pavilion" as its registered trademark. Among them, Qiangli Loquat Paste (Honey Refining) is the exclusive variety of the country (the product production process has obtained a national invention patent) and a traditional Chinese medicine protection variety. It has been entered into the national new version of the medical insurance catalog in 2017. Qiangli loquat paste (honey refining), Qiangli loquat paste, compound melon seed gold granules, Erbao paste, Jianerqing lyso solution, Shenqi deer antler oral liquid, and Shenbao syrup are the flagship products of Tengwangge Pharmaceutical and are sold all over the country.
Jiangxi Tengwangge Pharmaceutical Co., Ltd.
Jiangxi Tengwangge Pharmaceutical Co., Ltd. (hereinafter referred to as "Tengwangge Pharmaceutical") was established in 1989. After its transformation, it has become a Sino-foreign joint venture and mainly produces Chinese patent medicines. It is now located in the beautiful scenery of Changbei Economic Development Zone, Nanchang City. Meilingjiao covers an area of 68 mu, with a factory building and its auxiliary building area of 16,800 square meters. The company currently has 160 employees, 73 people with college degree or above, accounting for 45.6%, of which 39 people with scientific and technological personnel, accounting for 24.3%. The scientific and technological research and development team covers multiple majors such as pharmacy, traditional Chinese medicine, pharmaceutical engineering, bioengineering, and mechanical manufacturing. The company has the domestic advanced Chinese medicine extraction and concentration production line, granule preparation production line, oral liquid production line, as well as two decoction and syrup production lines integrating automatic bottle washing, filling, capping, cleaning, drying and labeling of bottles; It has a total of 52 varieties and more than 100 specifications of various products with "Tengwang Pavilion" as its registered trademark. Among them, Qiangli Loquat Paste (Honey Refining) is the exclusive variety of the country (the product production process has obtained a national invention patent) and a traditional Chinese medicine protection variety. It has been entered into the national new version of the medical insurance catalog in 2017. Qiangli loquat paste (honey refining), Qiangli loquat paste, compound melon seed gold granules, Erbao paste, Jianerqing lyso solution, Shenqi deer antler oral liquid, and Shenbao syrup are the flagship products of Tengwangge Pharmaceutical and are sold all over the country.
Hunan Xinhui Pharmaceutical Co., Ltd.
Hunan Xinhui Pharmaceutical Co., Ltd. is a core leading enterprise established by Chairman and General Manager of Changsha Xinquan Xinlin Health Industry (Headquarters) Co., Ltd. In May 2002, based on the acquisition of the former state-owned bankrupt enterprise Hunan Xiangmin Pharmaceutical Factory It has been established and has produced more than 40 varieties of Houtou Jianweiling Tablets, Houtou Jianweiling Capsules, Shenjian Brain Liquid, Jiuwei Gantai Capsules, Snake Dan Chuanbei Loquat Paste for many years. Five production workshops, including pretreatment (including Chinese medicine extraction), solid preparations, liquid preparations, Chinese herbal medicine tablets, Chinese medicine formula granules, and modern comprehensive scientific research building, bioengineering center and pharmaceutical company, with a construction area of more than 40,000 square meters. Equipped with six domestic professional dosage forms and six production lines, production and processing equipment for Chinese herbal medicines and Chinese herbal formula granules. The annual production capacity of preparations, Chinese herbal medicines and Chinese herbal formula granules is more than 1 billion yuan respectively. It is a collection of new drug development, Chinese herbal medicine preparations, Chinese herbal medicines, and Chinese herbal medicines. A modern high-tech pharmaceutical enterprise integrating the production and sales of formula granules, bioengineering products and health products. The company unswervingly implements the innovation-driven strategy and implements management innovation and technological innovation alongside each other. First, the business philosophy of "producing safe drugs and being sincere to the people of the world" was laid. The "building of a integrity cultural management system for pharmaceutical enterprises" has been innovated, and the concept of integrity cultural inclusion in the entire value chain of pharmaceutical production and operation. Driven by the innovation strategy, the company has formed a 10,000-acre Chinese medicinal materials planting base with Xinhui Pharmaceutical Co., Ltd. as the core leading enterprise, and the entire traditional Chinese medicine industry chain and medicine for the production and sales of Chinese herbal medicine tablets, Chinese herbal formula granules, Chinese herbal preparations and health products. The mycelium raw material industry chain of dual-use biologically active substances has successfully achieved effective extension of the health industry.
Hunan Xinhui Pharmaceutical Co., Ltd.
Hunan Xinhui Pharmaceutical Co., Ltd. is a core leading enterprise established by Chairman and General Manager of Changsha Xinquan Xinlin Health Industry (Headquarters) Co., Ltd. In May 2002, based on the acquisition of the former state-owned bankrupt enterprise Hunan Xiangmin Pharmaceutical Factory It has been established and has produced more than 40 varieties of Houtou Jianweiling Tablets, Houtou Jianweiling Capsules, Shenjian Brain Liquid, Jiuwei Gantai Capsules, Snake Dan Chuanbei Loquat Paste for many years. Five production workshops, including pretreatment (including Chinese medicine extraction), solid preparations, liquid preparations, Chinese herbal medicine tablets, Chinese medicine formula granules, and modern comprehensive scientific research building, bioengineering center and pharmaceutical company, with a construction area of more than 40,000 square meters. Equipped with six domestic professional dosage forms and six production lines, production and processing equipment for Chinese herbal medicines and Chinese herbal formula granules. The annual production capacity of preparations, Chinese herbal medicines and Chinese herbal formula granules is more than 1 billion yuan respectively. It is a collection of new drug development, Chinese herbal medicine preparations, Chinese herbal medicines, and Chinese herbal medicines. A modern high-tech pharmaceutical enterprise integrating the production and sales of formula granules, bioengineering products and health products. The company unswervingly implements the innovation-driven strategy and implements management innovation and technological innovation alongside each other. First, the business philosophy of "producing safe drugs and being sincere to the people of the world" was laid. The "building of a integrity cultural management system for pharmaceutical enterprises" has been innovated, and the concept of integrity cultural inclusion in the entire value chain of pharmaceutical production and operation. Driven by the innovation strategy, the company has formed a 10,000-acre Chinese medicinal materials planting base with Xinhui Pharmaceutical Co., Ltd. as the core leading enterprise, and the entire traditional Chinese medicine industry chain and medicine for the production and sales of Chinese herbal medicine tablets, Chinese herbal formula granules, Chinese herbal preparations and health products. The mycelium raw material industry chain of dual-use biologically active substances has successfully achieved effective extension of the health industry.
Fuyuan Pharmaceutical Co., Ltd.
Fuyuan Pharmaceutical Co., Ltd. is located in Xuancheng, Anhui Province. In August 2018, it became a wholly-owned subsidiary of Beijing Fuyuan Pharmaceutical Co., Ltd., mainly engaged in topical ointments, creams, tinctures, topical solutions, tablets, granules, etc. The production and sales of more than 30 varieties of dosage forms, including Kesterol, Hassinid solution, erythromycin ointment, etc. International business has passed the GMP inspection of the US FDA, and the GMP certification of the FDA in the Philippines, Nigeria, Kenya, Ethiopia and other countries, and has been exported to many countries such as Africa and Southeast Asia.
Fuyuan Pharmaceutical Co., Ltd.
Fuyuan Pharmaceutical Co., Ltd. is located in Xuancheng, Anhui Province. In August 2018, it became a wholly-owned subsidiary of Beijing Fuyuan Pharmaceutical Co., Ltd., mainly engaged in topical ointments, creams, tinctures, topical solutions, tablets, granules, etc. The production and sales of more than 30 varieties of dosage forms, including Kesterol, Hassinid solution, erythromycin ointment, etc. International business has passed the GMP inspection of the US FDA, and the GMP certification of the FDA in the Philippines, Nigeria, Kenya, Ethiopia and other countries, and has been exported to many countries such as Africa and Southeast Asia.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Guangzhou Baiyunshan Hutchison Huangpu Traditional Chinese Medicine Co., Ltd. (hereinafter referred to as "Baiyunshan Hutchison Huangpu") was jointly established in May 2005 by the Baiyunshan Pharmaceutical Co., Ltd., a subsidiary of Guangzhou Pharmaceutical Group and Hutchison Huangpu (China) Company, a subsidiary of Mr. Li Ka-shing. The joint venture was formerly known as Guangzhou Baiyunshan Traditional Chinese Medicine Factory. It was established in May 1988. It was derived from the farm operation area established in 1956 and was transformed into a tonic factory that combines agriculture and industry, and then transformed into Guangzhou Baiyun, which operates the pharmaceutical and health industry. Shan Chinese Medicine Factory. The company stands at the forefront of the times and the height of the industry, takes the cross policy of "education, love, technology, innovation, responsibility" as a guide, and takes the mission of "modernization of traditional Chinese medicine, internationalization of traditional Chinese medicine, popularization of traditional Chinese medicine, and popularization of traditional Chinese medicine" as its mission, and takes economic benefits. As the center, we focus on management internally, expand the market externally, and implement the three major strategies of "talent, brand, and technology", forming five core competitive advantages: scientific and technological innovation, responsible marketing, cultural heritage, talent engineering, and advanced party building. Especially since 1999, the company has entered a period of rapid growth and achieved leapfrog development. From 1999 to 2013, the scale of the enterprise expanded by 30 times, and the four indicators of sales, collection, output value and profit maintained a growth of more than 30%. The company actively builds a pioneer modern Chinese medicine enterprise and enters into advantageous enterprises in the big health industry.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Guangzhou Baiyunshan Hutchison Huangpu Traditional Chinese Medicine Co., Ltd. (hereinafter referred to as "Baiyunshan Hutchison Huangpu") was jointly established in May 2005 by the Baiyunshan Pharmaceutical Co., Ltd., a subsidiary of Guangzhou Pharmaceutical Group and Hutchison Huangpu (China) Company, a subsidiary of Mr. Li Ka-shing. The joint venture was formerly known as Guangzhou Baiyunshan Traditional Chinese Medicine Factory. It was established in May 1988. It was derived from the farm operation area established in 1956 and was transformed into a tonic factory that combines agriculture and industry, and then transformed into Guangzhou Baiyun, which operates the pharmaceutical and health industry. Shan Chinese Medicine Factory. The company stands at the forefront of the times and the height of the industry, takes the cross policy of "education, love, technology, innovation, responsibility" as a guide, and takes the mission of "modernization of traditional Chinese medicine, internationalization of traditional Chinese medicine, popularization of traditional Chinese medicine, and popularization of traditional Chinese medicine" as its mission, and takes economic benefits. As the center, we focus on management internally, expand the market externally, and implement the three major strategies of "talent, brand, and technology", forming five core competitive advantages: scientific and technological innovation, responsible marketing, cultural heritage, talent engineering, and advanced party building. Especially since 1999, the company has entered a period of rapid growth and achieved leapfrog development. From 1999 to 2013, the scale of the enterprise expanded by 30 times, and the four indicators of sales, collection, output value and profit maintained a growth of more than 30%. The company actively builds a pioneer modern Chinese medicine enterprise and enters into advantageous enterprises in the big health industry.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Guangzhou Baiyunshan Pan Gaoshou Pharmaceutical Co., Ltd. (hereinafter referred to as "Baiyunshan Pan Gaoshou") was founded in the 16th year of Guangxu in the Qing Dynasty (1890 AD) and is a "time-old Chinese brand". It is currently affiliated to Guangzhou Pharmaceutical Group Co., Ltd., and is a modern high-tech enterprise known for the research and development and production of Chinese patent medicines for relieving cough and phlegm. "Pan Gaoshou" was co-founded by the brothers Pan Baishi and Pan Yingshi from Kaiping, Guangdong. It was originally named "Changchundong Pan Gaoshou" pharmacy. In 1935, Pan Yusheng, the son of Pan Baishi, first created the "Chuanbei Loquat Lu in 1956, and the "Public-private joint venture Pan Gaoshou Joint Pharmaceutical Factory" was established. In 1980, the name of "Guangzhou Traditional Chinese Medicine Factory Seven" was abolished during the Cultural Revolution and the name of "Guangzhou Pan Gaoshou Pharmaceutical Factory" was restored. No. In 1993, the pharmaceutical factory was reorganized into "Guangzhou Pangaoshou Pharmaceutical Co., Ltd.". In 2012, it was renamed as "Guangzhou Baiyunshan Pangaoshou Pharmaceutical Co., Ltd.". Baiyun Mountain Pan Gaoshou is located at No. 9-11 Tianbao Road, Donghuan Street, Panyu District, Guangzhou. It covers an area of more than 50,000 square meters, has a construction area of 80,000 square meters, and has a greening area of 80%. It is a modern pharmaceutical manufacturing built in accordance with national GMP standards. enterprise. The existing production equipment configuration has reached the advanced domestic and international level, and a complete set of quality management systems have been established. Baiyunshan Pan Gaoshou mainly produces traditional Chinese medicine preparations, and has a product series covering four major fields, including respiratory, pediatrics, gynecology/oncology, health food, and more than 40 varieties of 5 major dosage forms. "Cough treatment for a hundred years, real material", Chuanbei loquat dew is the first in China. It is the company's four pillar products, including snake gallbladder Chuanbei liquid, snake gallbladder Chuanbei loquat paste, and honey-refined Chuanbei loquat paste. They are all Guangdong Province. "High-tech products", among which the cough-treated Sichuan Loquat Dew and honey-refined Sichuan Loquat Paste are the exclusive varieties in China. Xingsu cough relief oral liquid, yin-clearing lung mixture, Pinellia syrup, Sangju cold mixture, etc., pediatric medicines for children, Qingreli lung oral liquid, Clear heat and moisture oral liquid, Qixing Tea Syrup, etc., Gynecology The medicine Danbi Capsules, Ginseng Shuo Shuo Shuo, Yipu products, and many other categories are popular among consumers. The subsidiary Guangzhou Pan Gaoshou Natural Health Products Company mainly produces Sichuan loquat sugar, throat lozenges, turtle jelly, herbal tea and other foods and health foods, so as to achieve the "two-wings flying" of medicines and food.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Guangzhou Baiyunshan Pan Gaoshou Pharmaceutical Co., Ltd. (hereinafter referred to as "Baiyunshan Pan Gaoshou") was founded in the 16th year of Guangxu in the Qing Dynasty (1890 AD) and is a "time-old Chinese brand". It is currently affiliated to Guangzhou Pharmaceutical Group Co., Ltd., and is a modern high-tech enterprise known for the research and development and production of Chinese patent medicines for relieving cough and phlegm. "Pan Gaoshou" was co-founded by the brothers Pan Baishi and Pan Yingshi from Kaiping, Guangdong. It was originally named "Changchundong Pan Gaoshou" pharmacy. In 1935, Pan Yusheng, the son of Pan Baishi, first created the "Chuanbei Loquat Lu in 1956, and the "Public-private joint venture Pan Gaoshou Joint Pharmaceutical Factory" was established. In 1980, the name of "Guangzhou Traditional Chinese Medicine Factory Seven" was abolished during the Cultural Revolution and the name of "Guangzhou Pan Gaoshou Pharmaceutical Factory" was restored. No. In 1993, the pharmaceutical factory was reorganized into "Guangzhou Pangaoshou Pharmaceutical Co., Ltd.". In 2012, it was renamed as "Guangzhou Baiyunshan Pangaoshou Pharmaceutical Co., Ltd.". Baiyun Mountain Pan Gaoshou is located at No. 9-11 Tianbao Road, Donghuan Street, Panyu District, Guangzhou. It covers an area of more than 50,000 square meters, has a construction area of 80,000 square meters, and has a greening area of 80%. It is a modern pharmaceutical manufacturing built in accordance with national GMP standards. enterprise. The existing production equipment configuration has reached the advanced domestic and international level, and a complete set of quality management systems have been established. Baiyunshan Pan Gaoshou mainly produces traditional Chinese medicine preparations, and has a product series covering four major fields, including respiratory, pediatrics, gynecology/oncology, health food, and more than 40 varieties of 5 major dosage forms. "Cough treatment for a hundred years, real material", Chuanbei loquat dew is the first in China. It is the company's four pillar products, including snake gallbladder Chuanbei liquid, snake gallbladder Chuanbei loquat paste, and honey-refined Chuanbei loquat paste. They are all Guangdong Province. "High-tech products", among which the cough-treated Sichuan Loquat Dew and honey-refined Sichuan Loquat Paste are the exclusive varieties in China. Xingsu cough relief oral liquid, yin-clearing lung mixture, Pinellia syrup, Sangju cold mixture, etc., pediatric medicines for children, Qingreli lung oral liquid, Clear heat and moisture oral liquid, Qixing Tea Syrup, etc., Gynecology The medicine Danbi Capsules, Ginseng Shuo Shuo Shuo, Yipu products, and many other categories are popular among consumers. The subsidiary Guangzhou Pan Gaoshou Natural Health Products Company mainly produces Sichuan loquat sugar, throat lozenges, turtle jelly, herbal tea and other foods and health foods, so as to achieve the "two-wings flying" of medicines and food.
Harbin Kanglong Pharmaceutical Co., Ltd.
Harbin Kanglong Pharmaceutical Co., Ltd. was founded in 2000 and is headquartered in Harbin Liming High-tech Development Zone. The factory area covers an area of nearly 100,000 square meters. After years of hard work, it has now developed into a high-tech pharmaceutical company integrating R&D, production and sales. The enterprises are highly recognized by the state, provincial and municipal governments and have become the weather vane for modern and innovative traditional Chinese medicine enterprises. The company's main products are sugar-free powerful loquat deer, concentrated pediatric cough-styrene oral liquid and Yanning syrup, all of which are varieties that combine multiple patents. Among them, the main product, sugar-free powerful loquat deer, is a national basic drug and national medical insurance variety. Building a modern high-tech traditional Chinese medicine industry is Kanglong Pharmaceutical's pursuit, and inheriting and innovating, developing and promoting traditional Chinese medicine culture is the responsibility and responsibility of enterprises to society. Kanglong Pharmaceutical actively participates in the reform and development of my country's health field, devotes itself to the big health industry, and focuses on the research of advanced technologies, pursues conscientious quality, and comprehensive modern management. While focusing on the innovative development and protection of traditional Chinese patent medicines, Kanglong Pharmaceutical has continuously broadened its industry boundaries, explored the future of the industry, and provided people with a variety of life and health services. Over the years, Kanglong Pharmaceutical has adhered to the strategic plan of "quality survival, integrity development, brand market, and international pharmaceutical companies", continuously deepened reforms, innovation and change, won the trust of consumers and won the same industry. wide recognition. Harbin Kanglong Pharmaceutical Co., Ltd. is leading the same industry to face the Chaoyang and moving towards a higher and stronger field of medicine.
Harbin Kanglong Pharmaceutical Co., Ltd.
Harbin Kanglong Pharmaceutical Co., Ltd. was founded in 2000 and is headquartered in Harbin Liming High-tech Development Zone. The factory area covers an area of nearly 100,000 square meters. After years of hard work, it has now developed into a high-tech pharmaceutical company integrating R&D, production and sales. The enterprises are highly recognized by the state, provincial and municipal governments and have become the weather vane for modern and innovative traditional Chinese medicine enterprises. The company's main products are sugar-free powerful loquat deer, concentrated pediatric cough-styrene oral liquid and Yanning syrup, all of which are varieties that combine multiple patents. Among them, the main product, sugar-free powerful loquat deer, is a national basic drug and national medical insurance variety. Building a modern high-tech traditional Chinese medicine industry is Kanglong Pharmaceutical's pursuit, and inheriting and innovating, developing and promoting traditional Chinese medicine culture is the responsibility and responsibility of enterprises to society. Kanglong Pharmaceutical actively participates in the reform and development of my country's health field, devotes itself to the big health industry, and focuses on the research of advanced technologies, pursues conscientious quality, and comprehensive modern management. While focusing on the innovative development and protection of traditional Chinese patent medicines, Kanglong Pharmaceutical has continuously broadened its industry boundaries, explored the future of the industry, and provided people with a variety of life and health services. Over the years, Kanglong Pharmaceutical has adhered to the strategic plan of "quality survival, integrity development, brand market, and international pharmaceutical companies", continuously deepened reforms, innovation and change, won the trust of consumers and won the same industry. wide recognition. Harbin Kanglong Pharmaceutical Co., Ltd. is leading the same industry to face the Chaoyang and moving towards a higher and stronger field of medicine.
Shanghai Magic Pharmaceutical Investment Management Co., Ltd.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (Company abbreviation: Shenqi Pharmaceutical) is a pharmaceutical manufacturing holding investment company specializing in the research and development and production of anti-tumor, cardiovascular and cerebrovascular, cold and cough relieving, children's medicines and antifungal drugs. and sales companies. The company is a listed company of A and B shares on the Shanghai Stock Exchange (stock code: A shares: 600613; B shares: 900904). The company's "magic" brand has a business history of more than 30 years. The company has formed a brand culture, brand awareness, reputation and influence of "magic national medicine, the most important thing in efficacy" across the country. Shenqi Pharmaceutical currently has 11 production bases in Guiyang, Longli, Duyun, and Luodian, covering a total area of about 1,000 mu. It has more than 10 dosage forms and 37 production lines, all of which have passed the national compliance inspection. Shenqi Pharmaceutical is investing in the construction of a new factory area in Guiyang High-tech Development Zone, covering an area of 300 acres. Shenqi Pharmaceutical will strive to build the new factory into a modern pharmaceutical technology industrial park that is efficient, economical, green and environmentally friendly, human-oriented, and sustainable. Shenqi Pharmaceutical adheres to the mission of "through continuous innovation, committed to providing high-quality products and services for people's health", and always adheres to the company's production quality policy of "quality is the magic, and efficacy is amazing". At the same time, the company also has famous domestic and foreign drugs. The research institution has established a long-term cooperative relationship and has developed 14 national medicines with independent intellectual property rights and more than 80 national invention patents. The company's R&D and technological innovation capabilities have been recognized by the society. The company's products include both prescription drugs and OTC varieties, mainly in eight major fields such as anti-tumor series, cardiovascular and cerebrovascular series, cough and cold series, magic doll children series, anti-fungal series, and nourishing products. 141 national drug-accurate font products , sold in more than 100 cities at or above the prefecture level in 31 provinces (cities, autonomous regions) across the country. While growing and growing, Fanqi Pharmaceutical has always maintained a strong sense of social responsibility and never forgets to repay the society. It has donated more than 200 million yuan to pave roads and bridges in Guizhou, targeted assistance to farmers in poor areas, and built primary and secondary schools. It has also invested in establishing "Poor Student Scholarships" at Beijing University of Traditional Chinese Medicine, Shenyang Pharmaceutical University and Guizhou University of Nationalities to help poor students complete Study. In March 2002, the "Guangcai Rehabilitation Project" was implemented, and 120 million yuan of anti-tuberculosis drug pasoniazid tablets (formerly tuberculosis Kangxin tablets) were provided free of charge to 12 poor counties in Africa and the west through the Ministry of Health.
Shanghai Magic Pharmaceutical Investment Management Co., Ltd.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (Company abbreviation: Shenqi Pharmaceutical) is a pharmaceutical manufacturing holding investment company specializing in the research and development and production of anti-tumor, cardiovascular and cerebrovascular, cold and cough relieving, children's medicines and antifungal drugs. and sales companies. The company is a listed company of A and B shares on the Shanghai Stock Exchange (stock code: A shares: 600613; B shares: 900904). The company's "magic" brand has a business history of more than 30 years. The company has formed a brand culture, brand awareness, reputation and influence of "magic national medicine, the most important thing in efficacy" across the country. Shenqi Pharmaceutical currently has 11 production bases in Guiyang, Longli, Duyun, and Luodian, covering a total area of about 1,000 mu. It has more than 10 dosage forms and 37 production lines, all of which have passed the national compliance inspection. Shenqi Pharmaceutical is investing in the construction of a new factory area in Guiyang High-tech Development Zone, covering an area of 300 acres. Shenqi Pharmaceutical will strive to build the new factory into a modern pharmaceutical technology industrial park that is efficient, economical, green and environmentally friendly, human-oriented, and sustainable. Shenqi Pharmaceutical adheres to the mission of "through continuous innovation, committed to providing high-quality products and services for people's health", and always adheres to the company's production quality policy of "quality is the magic, and efficacy is amazing". At the same time, the company also has famous domestic and foreign drugs. The research institution has established a long-term cooperative relationship and has developed 14 national medicines with independent intellectual property rights and more than 80 national invention patents. The company's R&D and technological innovation capabilities have been recognized by the society. The company's products include both prescription drugs and OTC varieties, mainly in eight major fields such as anti-tumor series, cardiovascular and cerebrovascular series, cough and cold series, magic doll children series, anti-fungal series, and nourishing products. 141 national drug-accurate font products , sold in more than 100 cities at or above the prefecture level in 31 provinces (cities, autonomous regions) across the country. While growing and growing, Fanqi Pharmaceutical has always maintained a strong sense of social responsibility and never forgets to repay the society. It has donated more than 200 million yuan to pave roads and bridges in Guizhou, targeted assistance to farmers in poor areas, and built primary and secondary schools. It has also invested in establishing "Poor Student Scholarships" at Beijing University of Traditional Chinese Medicine, Shenyang Pharmaceutical University and Guizhou University of Nationalities to help poor students complete Study. In March 2002, the "Guangcai Rehabilitation Project" was implemented, and 120 million yuan of anti-tuberculosis drug pasoniazid tablets (formerly tuberculosis Kangxin tablets) were provided free of charge to 12 poor counties in Africa and the west through the Ministry of Health.
Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd. (hereinafter referred to as "Baiyunshan Guanghua"), Tang Shiyi Pharmaceutical Factory, founded in 1912, is one of the earliest Xizhuang Pharmaceutical Factory in South China. Guided by party building, build a modern pharmaceutical enterprise. Baiyunshan Guanghua has always adhered to the guidance of party building and led all cadres and employees to realize the "Guanghua Dream" of building a modern production base. The company has more than 400 high-quality talent teams, with professional and technical personnel accounting for 46.7%. The talent strategy with "dual track channel" as the core ensures the talent training and sustainable development of the enterprise, and forms a new atmosphere of streamlined, efficient and equal development. . The company has always adhered to the business philosophy of "creating advanced through technology and creating brand with quality", and is committed to making good medicine and being a safe medicine in the hearts of the people. Featured with slow-release, quick-release effervescent and chewable tablets, the drugs developed include cold medicine, cardiovascular and cerebrovascular medicine, anti-inflammatory and cough relieving, digestive tract, vitamin calcium supplementation, nutritional and health care, women and children, and There are eight major series of Western medicine and antibiotics, including 263 drug approval numbers. The company's original "Hesui Brand" Ammonia Huangmin Capsule (original quick-acting cold capsule), Naoluotong Capsule, Oyster Calcium Carbonate Series, Xiao Chaihu Granules, theophylline Ephedrine Tablets (original Xizhangling Tablets), Lianzhi Anti-inflammatory Capsules and other products are listed as "national high-quality and high-priced products" and "Guangdong Province's independent innovation products".
Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd. (hereinafter referred to as "Baiyunshan Guanghua"), Tang Shiyi Pharmaceutical Factory, founded in 1912, is one of the earliest Xizhuang Pharmaceutical Factory in South China. Guided by party building, build a modern pharmaceutical enterprise. Baiyunshan Guanghua has always adhered to the guidance of party building and led all cadres and employees to realize the "Guanghua Dream" of building a modern production base. The company has more than 400 high-quality talent teams, with professional and technical personnel accounting for 46.7%. The talent strategy with "dual track channel" as the core ensures the talent training and sustainable development of the enterprise, and forms a new atmosphere of streamlined, efficient and equal development. . The company has always adhered to the business philosophy of "creating advanced through technology and creating brand with quality", and is committed to making good medicine and being a safe medicine in the hearts of the people. Featured with slow-release, quick-release effervescent and chewable tablets, the drugs developed include cold medicine, cardiovascular and cerebrovascular medicine, anti-inflammatory and cough relieving, digestive tract, vitamin calcium supplementation, nutritional and health care, women and children, and There are eight major series of Western medicine and antibiotics, including 263 drug approval numbers. The company's original "Hesui Brand" Ammonia Huangmin Capsule (original quick-acting cold capsule), Naoluotong Capsule, Oyster Calcium Carbonate Series, Xiao Chaihu Granules, theophylline Ephedrine Tablets (original Xizhangling Tablets), Lianzhi Anti-inflammatory Capsules and other products are listed as "national high-quality and high-priced products" and "Guangdong Province's independent innovation products".
Jiangxi Huiren Pharmaceutical Co., Ltd. was founded in 1992 and officially put into production in 1994. It is headquartered in Xiaolan Industrial Park, the National Economic Development Zone. It is a large pharmaceutical enterprise focusing on the research and development, production, and sales of traditional Chinese patent medicines in the category of tonics. Currently, the company has more than 100 products including Shenbao Tablets, Nujin Capsules, Ganshenan Granules, Liuwei Dihuang Pills, Jiedu Acne Pills, Liqi Nuanwei Granules, etc., including more than 100 new Chinese medicine varieties, including Shenbao Tablets, Nuanwei Capsules, etc. Among them, Shenbao Tablets belong to the results of the national "863" plan and the national second-level traditional Chinese medicine protected variety. Now, Huiren has formed more than 10 series of supplementary products, including gynecological and pediatrics, and digestive system Chinese patent medicines, and 9 dosage forms and more than 100 specifications. At present, the company produces traditional Chinese medicine kidney-tonifying products mainly based on Shenbao tablets. In the future, the company will enrich the entire product echelon of the conditioning and tonic category and continue to expand and strengthen the kidney-tonifying category. The company invested heavily in the construction of the enterprise R&D center in the Shanghai Zhangjiang High-Tech Park in China Pharmaceutical Valley. The center has a large-scale pilot platform open to the whole country and a large number of advanced instruments and equipment facilities. The R&D center has established a postdoctoral workstation and has successively introduced more than 20 high-level medical research talents, including doctoral supervisors, postdoctoral fellows, doctoral students, etc. For a long time, technical cooperation has been carried out with research institutes such as the Chinese Academy of Traditional Chinese Medicine, the Institute of Medicinal Plants of the Chinese Academy of Medical Sciences, the Shanghai Institute of Pharmaceuticals of the Chinese Academy of Sciences, the Chinese Association of Traditional Chinese Medicine, Jiangxi Academy of Forestry Sciences, and Jiangxi University of Traditional Chinese Medicine, and has completed more than 100 drugs. (Project) development, more than 50 new drug certificates or production approval documents have been obtained. The company has a complete quality management system and manufacturing system. Huiren has always adhered to the quality policy of "authenticity, law, morality, making high-quality products, loving jobs, loving careers, loving people, and loving hearts", and has "becoming a high-quality model of China's pharmaceutical industry and becoming a trustworthy smart manufacturing of health products. "For the goal of strengthening quality management, selecting authentic and high-quality medicinal materials, adopting traditional preparation techniques, using modern intelligent technology, carrying forward the spirit of craftsmanship, and committed to providing consumers with safe, effective and high-quality products.
Huiren Group Co., Ltd.
Jiangxi Huiren Pharmaceutical Co., Ltd. was founded in 1992 and officially put into production in 1994. It is headquartered in Xiaolan Industrial Park, the National Economic Development Zone. It is a large pharmaceutical enterprise focusing on the research and development, production, and sales of traditional Chinese patent medicines in the category of tonics. Currently, the company has more than 100 products including Shenbao Tablets, Nujin Capsules, Ganshenan Granules, Liuwei Dihuang Pills, Jiedu Acne Pills, Liqi Nuanwei Granules, etc., including more than 100 new Chinese medicine varieties, including Shenbao Tablets, Nuanwei Capsules, etc. Among them, Shenbao Tablets belong to the results of the national "863" plan and the national second-level traditional Chinese medicine protected variety. Now, Huiren has formed more than 10 series of supplementary products, including gynecological and pediatrics, and digestive system Chinese patent medicines, and 9 dosage forms and more than 100 specifications. At present, the company produces traditional Chinese medicine kidney-tonifying products mainly based on Shenbao tablets. In the future, the company will enrich the entire product echelon of the conditioning and tonic category and continue to expand and strengthen the kidney-tonifying category. The company invested heavily in the construction of the enterprise R&D center in the Shanghai Zhangjiang High-Tech Park in China Pharmaceutical Valley. The center has a large-scale pilot platform open to the whole country and a large number of advanced instruments and equipment facilities. The R&D center has established a postdoctoral workstation and has successively introduced more than 20 high-level medical research talents, including doctoral supervisors, postdoctoral fellows, doctoral students, etc. For a long time, technical cooperation has been carried out with research institutes such as the Chinese Academy of Traditional Chinese Medicine, the Institute of Medicinal Plants of the Chinese Academy of Medical Sciences, the Shanghai Institute of Pharmaceuticals of the Chinese Academy of Sciences, the Chinese Association of Traditional Chinese Medicine, Jiangxi Academy of Forestry Sciences, and Jiangxi University of Traditional Chinese Medicine, and has completed more than 100 drugs. (Project) development, more than 50 new drug certificates or production approval documents have been obtained. The company has a complete quality management system and manufacturing system. Huiren has always adhered to the quality policy of "authenticity, law, morality, making high-quality products, loving jobs, loving careers, loving people, and loving hearts", and has "becoming a high-quality model of China's pharmaceutical industry and becoming a trustworthy smart manufacturing of health products. "For the goal of strengthening quality management, selecting authentic and high-quality medicinal materials, adopting traditional preparation techniques, using modern intelligent technology, carrying forward the spirit of craftsmanship, and committed to providing consumers with safe, effective and high-quality products.
Hong Kong Kyoto Health Preservation Hall Pharmaceutical Factory Co., Ltd.
Hong Kong Kyoto Yangshengtang Pharmaceutical Factory Co., Ltd. is located in the New Territories of Hong Kong. It is a comprehensive pharmaceutical enterprise integrating pharmaceutical production, research and development and sales. With consistent quality pursuit, Kyoto Health Department, Hong Kong has won praise from customers for its good product results and professional traditional Chinese medicine services. "Inheriting the essence of traditional Chinese medicine and benefiting people's health", Kyoto Health Hall in Hong Kong has always been committed to developing the traditional Chinese medicine industry in the motherland and providing the people with high-quality products and professional traditional Chinese medicine services. The Kyoto Health Hall in Hong Kong has been constantly exploring the essence of traditional Chinese medicine, pioneering and innovating, carefully selecting and verifying the prescriptions of thousands of years, organically combining traditional fabrication with modern technology, and innovatively developing the Pinellia Loquat Paste and Sugar Paste High-quality products such as Jinjianluo oil. The Kyoto Health Hall in Hong Kong actively learns Chinese medicine knowledge and cultivates a service team with more than 500 people with high professional knowledge to provide professional medical services for the health and wellness of the people. The company has always adhered to the management concept of "people-oriented, quality-first, and scientific development", continuously optimized production processes and improved the management level of the enterprise. In terms of talent strategy, Kyoto Health Hall in Hong Kong has carried out in-depth cooperation with many universities, introducing technical talents from well-known universities such as the University of Hong Kong, the National University of Singapore, Sun Yat-sen University, and China Pharmaceutical University, and carrying out talent exchanges between Hong Kong and the Mainland to provide talents with talents High-quality development platform. At the same time, Hong Kong Kyoto Health Department actively introduces internationally leading automated production, continuously optimizes the production process of products, and safeguards product quality.
Hong Kong Kyoto Health Preservation Hall Pharmaceutical Factory Co., Ltd.
Hong Kong Kyoto Yangshengtang Pharmaceutical Factory Co., Ltd. is located in the New Territories of Hong Kong. It is a comprehensive pharmaceutical enterprise integrating pharmaceutical production, research and development and sales. With consistent quality pursuit, Kyoto Health Department, Hong Kong has won praise from customers for its good product results and professional traditional Chinese medicine services. "Inheriting the essence of traditional Chinese medicine and benefiting people's health", Kyoto Health Hall in Hong Kong has always been committed to developing the traditional Chinese medicine industry in the motherland and providing the people with high-quality products and professional traditional Chinese medicine services. The Kyoto Health Hall in Hong Kong has been constantly exploring the essence of traditional Chinese medicine, pioneering and innovating, carefully selecting and verifying the prescriptions of thousands of years, organically combining traditional fabrication with modern technology, and innovatively developing the Pinellia Loquat Paste and Sugar Paste High-quality products such as Jinjianluo oil. The Kyoto Health Hall in Hong Kong actively learns Chinese medicine knowledge and cultivates a service team with more than 500 people with high professional knowledge to provide professional medical services for the health and wellness of the people. The company has always adhered to the management concept of "people-oriented, quality-first, and scientific development", continuously optimized production processes and improved the management level of the enterprise. In terms of talent strategy, Kyoto Health Hall in Hong Kong has carried out in-depth cooperation with many universities, introducing technical talents from well-known universities such as the University of Hong Kong, the National University of Singapore, Sun Yat-sen University, and China Pharmaceutical University, and carrying out talent exchanges between Hong Kong and the Mainland to provide talents with talents High-quality development platform. At the same time, Hong Kong Kyoto Health Department actively introduces internationally leading automated production, continuously optimizes the production process of products, and safeguards product quality.
Huizhou Haitiantang Health Products Co., Ltd.
When he was young, Mr. Wu Yaoming, the founder of Haitian Tang, had set up "Haitian Game" on Shanghai Street in Jordan to sell effective game and engage in business related to turtles. In the 1970s, Mr. Wu was even more committed to studying the effects of Turtle Poria jelly on human health and health because of his stubborn disease. At that time, the weak old lady Wu was less than 100 pounds, but after taking Turtle Poria jelly, her health gradually improved. Finally, she Weight returns to 140-150 pounds. After word of mouth among friends, many people asked Mr. Wu to make turtle jelly for them. Mr. Wu was overwhelmed, so he established the first Haitian fresh turtle jelly on Baoling Street, Jordan in 1991. In less than 18 years, chain-operated branches have developed to the province, Hong Kong, Macao and even overseas. This achievement is entirely due to the various turtle pulp sausages carefully studied by Mr. Wu, and the selection of fresh turtle and multi-flavor Chinese medicinal materials. The real ingredients can not only clear heat and toxins, eliminate breath, protect skin and nourish skin. , and can improve the function of organs in the body, promote metabolism, skin dampness and toxins, sore throat, prickly nourishment, constipation, vomiting and stomachache, etc. In addition, the Hong Kong legend of Turtle Poria jelly can produce therapeutic effects by "Turle Poria jelly eating", making Haitiantang a famous Turtle Poria jelly brand in Hong Kong and even Asia. In addition to Turtle Pill Jelly, Haitiantang is also committed to developing a series of healthy beverages, moisturizing series and healthy products to ensure that each product is real and strives to meet consumers' health requirements. Diet therapy can make people healthy and live long. The right choice is the way to maintain health. Haitiantang makes wholehearted efforts for your health.
Huizhou Haitiantang Health Products Co., Ltd.
When he was young, Mr. Wu Yaoming, the founder of Haitian Tang, had set up "Haitian Game" on Shanghai Street in Jordan to sell effective game and engage in business related to turtles. In the 1970s, Mr. Wu was even more committed to studying the effects of Turtle Poria jelly on human health and health because of his stubborn disease. At that time, the weak old lady Wu was less than 100 pounds, but after taking Turtle Poria jelly, her health gradually improved. Finally, she Weight returns to 140-150 pounds. After word of mouth among friends, many people asked Mr. Wu to make turtle jelly for them. Mr. Wu was overwhelmed, so he established the first Haitian fresh turtle jelly on Baoling Street, Jordan in 1991. In less than 18 years, chain-operated branches have developed to the province, Hong Kong, Macao and even overseas. This achievement is entirely due to the various turtle pulp sausages carefully studied by Mr. Wu, and the selection of fresh turtle and multi-flavor Chinese medicinal materials. The real ingredients can not only clear heat and toxins, eliminate breath, protect skin and nourish skin. , and can improve the function of organs in the body, promote metabolism, skin dampness and toxins, sore throat, prickly nourishment, constipation, vomiting and stomachache, etc. In addition, the Hong Kong legend of Turtle Poria jelly can produce therapeutic effects by "Turle Poria jelly eating", making Haitiantang a famous Turtle Poria jelly brand in Hong Kong and even Asia. In addition to Turtle Pill Jelly, Haitiantang is also committed to developing a series of healthy beverages, moisturizing series and healthy products to ensure that each product is real and strives to meet consumers' health requirements. Diet therapy can make people healthy and live long. The right choice is the way to maintain health. Haitiantang makes wholehearted efforts for your health.
Ricola is a well-known manufacturer of throat and mints in Switzerland. The company was established in 1930, and its headquarters was established in the Swiss city of Lefen, emphasizing the natural herbal materials used during production. Swiss Liqueur Natural Vanilla Sugar, unique flavor and refreshing and moisturizing. In order to cater to different consumers' preferences, Liqueur is also available in original flavors, lemon and extra strong mint for choice. In the early 1980s, Hong Kong Liquor Mint Advertising invited the well-known Cantonese film The Gang Kao Shi Jian to perform, successfully creating the image of "the traitor has its own tricks" for the brand, which was deeply rooted in the hearts of the people. In order to maintain a clear voice, the well-known king Michael Jackson usually adds two drops of Ricola to a cup of hot water before drinking it.
DKSH Hong Kong Limited
Ricola is a well-known manufacturer of throat and mints in Switzerland. The company was established in 1930, and its headquarters was established in the Swiss city of Lefen, emphasizing the natural herbal materials used during production. Swiss Liqueur Natural Vanilla Sugar, unique flavor and refreshing and moisturizing. In order to cater to different consumers' preferences, Liqueur is also available in original flavors, lemon and extra strong mint for choice. In the early 1980s, Hong Kong Liquor Mint Advertising invited the well-known Cantonese film The Gang Kao Shi Jian to perform, successfully creating the image of "the traitor has its own tricks" for the brand, which was deeply rooted in the hearts of the people. In order to maintain a clear voice, the well-known king Michael Jackson usually adds two drops of Ricola to a cup of hot water before drinking it.
Jiasui (Shanghai) Trading Co., Ltd.
BLACKMORES is an Australian natural nutrition company focusing on providing consumers with safe and high-quality dietary nutrition supplements, infant formula, skin care products and health consulting services. Since its establishment in 1932, the company's business has grown to 17 markets around the world and has more than 1,000 employees. BLACKMORES continues to give back to the society through health education, environmental protection, community services, etc., and has become a leading health company trusted by global consumers.
Jiasui (Shanghai) Trading Co., Ltd.
BLACKMORES is an Australian natural nutrition company focusing on providing consumers with safe and high-quality dietary nutrition supplements, infant formula, skin care products and health consulting services. Since its establishment in 1932, the company's business has grown to 17 markets around the world and has more than 1,000 employees. BLACKMORES continues to give back to the society through health education, environmental protection, community services, etc., and has become a leading health company trusted by global consumers.
A global brand specializing in herbal products, including cough syrups and respiratory remedies.
Herbion International
A global brand specializing in herbal products, including cough syrups and respiratory remedies.
